|
Standard of Care Treatment Clinical Trials
3 actively recruiting trials across 3 locations
Pipeline
Phase 3: 2Phase 2/3: 1
Top Sponsors
- Janssen Research & Development, LLC2
- Kyverna Therapeutics1
Indications
- Sjogrens Syndrome1
- Lupus Erythematosus, Systemic1
- Lupus1
- Arthritis1
- Myasthenia Gravis1
Chula Vista, California1 trial
Nipocalimab in Moderate to Severe Sjogren's Disease
Advanced Clinical Research Center
Phase 3
La Palma, California1 trial
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Advanced Medical Research
Phase 3
Orange, California1 trial
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
University of California, Irvine
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.